These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Däschner K, Assum G, Eisenbarth I, Krone W, Hoffmeyer S, Wortmann S, Heymer B, Kehrer-Sawatzki H. Biochem Biophys Res Commun; 1997 May 19; 234(2):346-50. PubMed ID: 9177273 [Abstract] [Full Text] [Related]
3. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Mashour GA, Ratner N, Khan GA, Wang HL, Martuza RL, Kurtz A. Oncogene; 2001 Jan 04; 20(1):97-105. PubMed ID: 11244508 [Abstract] [Full Text] [Related]
5. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Lévy P, Bièche I, Leroy K, Parfait B, Wechsler J, Laurendeau I, Wolkenstein P, Vidaud M, Vidaud D. Clin Cancer Res; 2004 Jun 01; 10(11):3763-71. PubMed ID: 15173083 [Abstract] [Full Text] [Related]
6. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Waggoner DJ, Towbin J, Gottesman G, Gutmann DH. Am J Med Genet; 2000 May 15; 92(2):132-5. PubMed ID: 10797438 [Abstract] [Full Text] [Related]
7. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria. Odebode TO, Afolayan EA, Adigun IA, Daramola OO. Int J Dermatol; 2005 Feb 15; 44(2):116-20. PubMed ID: 15689208 [Abstract] [Full Text] [Related]
8. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas. Tucker T, Riccardi VM, Brown C, Fee J, Sutcliffe M, Vielkind J, Wechsler J, Wolkenstein P, Friedman JM. J Neurosci Res; 2011 Sep 15; 89(9):1451-60. PubMed ID: 21674567 [Abstract] [Full Text] [Related]
12. Fluorescence in situ hybridization analysis of allelic losses involving the long arm of chromosome 17 in NF1-associated neurofibromas. De Luca A, Bernardini L, Ceccarini C, Sinibaldi L, Novelli A, Giustini S, Daniele I, Calvieri S, Mingarelli R. Cancer Genet Cytogenet; 2004 Apr 15; 150(2):168-72. PubMed ID: 15066327 [Abstract] [Full Text] [Related]
14. Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation. Bartelt-Kirbach B, Wuepping M, Dodrimont-Lattke M, Kaufmann D. Neurogenetics; 2009 Feb 15; 10(1):79-85. PubMed ID: 18850118 [Abstract] [Full Text] [Related]
16. Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers. Wiest V, Eisenbarth I, Schmegner C, Krone W, Assum G. Hum Mutat; 2003 Dec 15; 22(6):423-7. PubMed ID: 14635100 [Abstract] [Full Text] [Related]
17. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Wallace MR, Rasmussen SA, Lim IT, Gray BA, Zori RT, Muir D. Genes Chromosomes Cancer; 2000 Feb 15; 27(2):117-23. PubMed ID: 10612798 [Abstract] [Full Text] [Related]